Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lexeo Therapeutics, Inc. (LXEO) has issued an update.
Bernard Davitian has informed Lexeo Therapeutics, Inc. that he will not seek re-election at the upcoming annual stockholders’ meeting. This decision is not fueled by any disputes or disagreements over the company’s operational, policy, or practice matters.
See more data about LXEO stock on TipRanks’ Stock Analysis page.